When the possibility of death is the only alternative, most people will opt for the most aggressive cancer treatments possible. The problem is, a new study by researchers at OHSU suggests that a robust combination of therapies that are effective in targeting the cancer can lead to harmful cognitive effects in the brain if the patient survives.

Long-term exposure to cosmic radiation could alter the brain and change behavior in astronauts bound for Mars, according to new research led by scientists at OHSU in Portland, Oregon.

Scientists for the first time have documented a newly understood pathway for transmitting signals within the brain, according research published online Nov. 9 in the journal Nature.

Families struggling with infertility or a genetic predisposition for debilitating mitochondrial diseases may someday benefit from a new breakthrough led by scientists at OHSU and the Salk Institute for Biological Studies.

New four-year demo project expands in-home tracking to households in Portland, Chicago and Miami.

In a new study published online today in The Journal of Neuroscience, researchers found that chronic administration of estradiol boosts cognitive performance in aged female rhesus monkeys.

A breakthrough study published online this week in the journal Nucleic Acids Research suggests that it may be possible to treat genetic disease detected in the womb by safely and efficiently delivering gene-altering therapies through a kind of reverse amniocentesis.

A panel of leading experts today issued the 4th Edition of the Guidelines for the Management of Severe Traumatic Brain Injury. The updated guidelines provide recommendations for 18 monitoring and treatment topics for patients with severe traumatic brain injuries, or TBI, including surgical procedures, the use of monitors that measure intracranial pressure, preventing and treating brain swelling, and nutrition.

Opioid abuse and addiction is a tremendous national problem, claiming thousands of lives and doubling the number of people who reported heroin addiction in a single decade (2003 to 2013).

New research reveals for the first time the atomic structures of a key molecular receptor in the brain, which opens the door for developing medications that could block activation of these receptors to address a variety of conditions, ranging from pain to high blood pressure to early formation of blood clots.